Medical Device | June 04, 2026
BPL MedTech unveils new ICU ventilator BPL Vent 300
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
The PRIOH-1 study met its primary endpoint, delivering statistically significant and clinically meaningful improvements in lesion healing
Galenicum will oversee development, manufacturing and supply, while Lupin will handle regulatory submissions, approvals, and commercialization and distribution of Semaglutide across 23 countries globally
Subscribe To Our Newsletter & Stay Updated
